Success Metrics

Clinical Success Rate
95.7%

Based on 22 completed trials

Completion Rate
96%(22/23)
Active Trials
5(13%)
Results Posted
23%(5 trials)
Terminated
1(3%)

Phase Distribution

Ph not_applicable
22
58%
Ph phase_3
2
5%
Ph phase_4
5
13%
Ph phase_1
1
3%

Phase Distribution

1

Early Stage

0

Mid Stage

7

Late Stage

Phase Distribution30 total trials
Phase 1Safety & dosage
1(3.3%)
Phase 3Large-scale testing
2(6.7%)
Phase 4Post-market surveillance
5(16.7%)
N/ANon-phased studies
22(73.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.0%

22 of 25 finished

Non-Completion Rate

12.0%

3 ended early

Currently Active

5

trials recruiting

Total Trials

38

all time

Status Distribution
Active(5)
Completed(22)
Terminated(3)
Other(8)

Detailed Status

Completed22
unknown8
Recruiting4
Withdrawn2
Active, not recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
38
Active
5
Success Rate
95.7%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (3.3%)
Phase 32 (6.7%)
Phase 45 (16.7%)
N/A22 (73.3%)

Trials by Status

withdrawn25%
active_not_recruiting13%
unknown821%
completed2258%
terminated13%
recruiting411%

Recent Activity

Clinical Trials (38)

Showing 20 of 38 trialsScroll for more
NCT05821855Phase 4

A Study to Evaluate Adverse Events and Change in Disease Activity With the XEN45 Glaucoma Treatment System Implantation In Adult Participants With Open-Angle Glaucoma in China

Active Not Recruiting
NCT07152132Not Applicable

SCTSC Versus Trabeculectomy in Medically Uncontrolled Open-Angle Glaucoma in Pseudophakic Patients

Recruiting
NCT01711190

Astigmatism Post-trabeculectomy

Completed
NCT04333433

PRESERFLO® MicroShunt Extension Study

Completed
NCT03931564Not Applicable

SIGHT Study: Cost-effectiveness of InnFocus Microshunt Implantation vs. Trabeculectomy.

Unknown
NCT05371977Not Applicable

Deep Sclerectomy Versus Trabeculectomy in Normal Tension Glaucoma

Recruiting
NCT04727411Not Applicable

Analysis of Conjunctival Changes as Indicators for Ab-interno Gelatin Microstent Implantation Surgery Outcomes

Completed
NCT00280345Not Applicable

Autoimmune Dysregulation in Pigmentary Glaucoma

Completed
NCT04647929Not Applicable

Comparison of Surgical Treatment Options for Primary Congenital and Developmental Glaucomas

Withdrawn
NCT03107000Not Applicable

Corneal Endothelial Cell Loss After Trabeculectomy Versus Phakotrabeculectomy

Completed
NCT04572880Not Applicable

Evaluation of Minimal Invasive Glaucoma Surgery

Unknown
NCT05340647

NorMIGS - a Study of Micro-invasive Glaucoma Surgery

Recruiting
NCT00666237Phase 4

Primary Tube Versus Trabeculectomy Study

Completed
NCT03654885Phase 4

XEN-45 Gel Stent Versus Trabeculectomy in Glaucoma: Gold-Standard Pathway Study (GPS)

Completed
NCT05163951Not Applicable

Trabeculectomy Versus Peripheral Iridectomy Plus Goniotomy in Advanced PACG

Recruiting
NCT05126069

Ab Interno Gelatin Microstent With MMC vs. Trabeculectomy With MMC: 3 Year Retrospective Cohort Analysis

Completed
NCT04648943Not Applicable

The Effect of Trabeculectomy & Ex-PRESS Glaucoma Drainage Implant on the Corneal Biomechanical Properties

Completed
NCT00444080Not Applicable

Comparison of Ex-PRESSTM Mini Glaucoma Shunt to Trabeculectomy in Subjects With Open Angle Glaucoma

Completed
NCT04440527Not Applicable

Intraocular Pressure After Preserflo / Innfocus Microshunt Implantation vs Trabeculectomy

Unknown
NCT01115218

The Influence of Anterior Chamber Fluid Mediators on the Success Rate of Trabeculectomy

Completed

Drug Details

Intervention Type
PROCEDURE
Total Trials
38